nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylprednisolone—brain cancer—Triamcinolone—hematologic cancer	0.0662	0.445	CpDpCtD
Methylprednisolone—Corticosteroid Hormone Receptor Agonists—Betamethasone—hematologic cancer	0.0556	0.209	CiPCiCtD
Methylprednisolone—Corticosteroid Hormone Receptor Agonists—Dexamethasone—hematologic cancer	0.0556	0.209	CiPCiCtD
Methylprednisolone—Corticosteroid Hormone Receptor Agonists—Triamcinolone—hematologic cancer	0.0537	0.202	CiPCiCtD
Methylprednisolone—NR3C1—hematologic cancer	0.0528	0.675	CbGaD
Methylprednisolone—Corticosteroid Hormone Receptor Agonists—Prednisolone—hematologic cancer	0.052	0.195	CiPCiCtD
Methylprednisolone—Corticosteroid Hormone Receptor Agonists—Prednisone—hematologic cancer	0.0491	0.185	CiPCiCtD
Methylprednisolone—Betamethasone—hematologic cancer	0.0392	0.208	CrCtD
Methylprednisolone—Dexamethasone—hematologic cancer	0.0392	0.208	CrCtD
Methylprednisolone—Triamcinolone—hematologic cancer	0.0383	0.203	CrCtD
Methylprednisolone—Prednisone—hematologic cancer	0.0364	0.193	CrCtD
Methylprednisolone—brain cancer—Dexamethasone—hematologic cancer	0.036	0.242	CpDpCtD
Methylprednisolone—brain cancer—Betamethasone—hematologic cancer	0.036	0.242	CpDpCtD
Methylprednisolone—Prednisolone—hematologic cancer	0.0355	0.188	CrCtD
Methylprednisolone—ABCB1—hematologic cancer	0.0255	0.326	CbGaD
Methylprednisolone—osteoarthritis—Prednisone—hematologic cancer	0.0106	0.0712	CpDpCtD
Methylprednisolone—NR3C1—Triamcinolone—hematologic cancer	0.00828	0.0768	CbGbCtD
Methylprednisolone—NR3C1—Betamethasone—hematologic cancer	0.0071	0.0659	CbGbCtD
Methylprednisolone—NR3C1—Prednisolone—hematologic cancer	0.00701	0.065	CbGbCtD
Methylprednisolone—NR3C1—Prednisone—hematologic cancer	0.00662	0.0614	CbGbCtD
Methylprednisolone—ABCB1—Lenalidomide—hematologic cancer	0.00521	0.0483	CbGbCtD
Methylprednisolone—NR3C1—Dexamethasone—hematologic cancer	0.00413	0.0383	CbGbCtD
Methylprednisolone—CYP3A4—Bexarotene—hematologic cancer	0.00312	0.029	CbGbCtD
Methylprednisolone—ABCB1—Daunorubicin—hematologic cancer	0.00305	0.0283	CbGbCtD
Methylprednisolone—ABCB1—Alitretinoin—hematologic cancer	0.00299	0.0278	CbGbCtD
Methylprednisolone—CYP3A4—Lomustine—hematologic cancer	0.0029	0.0269	CbGbCtD
Methylprednisolone—CYP3A4—Busulfan—hematologic cancer	0.0029	0.0269	CbGbCtD
Methylprednisolone—CYP3A4—Thiotepa—hematologic cancer	0.00259	0.024	CbGbCtD
Methylprednisolone—ABCB1—Imatinib—hematologic cancer	0.00234	0.0217	CbGbCtD
Methylprednisolone—ABCB1—Nilotinib—hematologic cancer	0.00213	0.0197	CbGbCtD
Methylprednisolone—ABCB1—Vinorelbine—hematologic cancer	0.00211	0.0196	CbGbCtD
Methylprednisolone—CYP3A4—Methoxsalen—hematologic cancer	0.00201	0.0187	CbGbCtD
Methylprednisolone—Exemestane—Prednisone—hematologic cancer	0.00193	0.0137	CrCrCtD
Methylprednisolone—CYP3A4—Bortezomib—hematologic cancer	0.00191	0.0178	CbGbCtD
Methylprednisolone—Exemestane—Prednisolone—hematologic cancer	0.00188	0.0134	CrCrCtD
Methylprednisolone—ABCB1—Dasatinib—hematologic cancer	0.00188	0.0174	CbGbCtD
Methylprednisolone—ABCB1—Mitoxantrone—hematologic cancer	0.00186	0.0172	CbGbCtD
Methylprednisolone—CYP3A4—Daunorubicin—hematologic cancer	0.00183	0.017	CbGbCtD
Methylprednisolone—ABCB1—Betamethasone—hematologic cancer	0.00165	0.0153	CbGbCtD
Methylprednisolone—ABCB1—Gemcitabine—hematologic cancer	0.00164	0.0152	CbGbCtD
Methylprednisolone—ABCB1—Prednisolone—hematologic cancer	0.00163	0.0151	CbGbCtD
Methylprednisolone—CYP3A4—Cytarabine—hematologic cancer	0.00161	0.015	CbGbCtD
Methylprednisolone—CYP3A4—Teniposide—hematologic cancer	0.00159	0.0148	CbGbCtD
Methylprednisolone—ABCB1—Prednisone—hematologic cancer	0.00154	0.0143	CbGbCtD
Methylprednisolone—CYP3A4—Ifosfamide—hematologic cancer	0.00147	0.0136	CbGbCtD
Methylprednisolone—ABCB1—Irinotecan—hematologic cancer	0.00146	0.0136	CbGbCtD
Methylprednisolone—CYP3A4—Imatinib—hematologic cancer	0.0014	0.013	CbGbCtD
Methylprednisolone—CYP3A4—Ruxolitinib—hematologic cancer	0.00132	0.0122	CbGbCtD
Methylprednisolone—ABCB1—Vinblastine—hematologic cancer	0.0013	0.0121	CbGbCtD
Methylprednisolone—Ciclesonide—Prednisone—hematologic cancer	0.00128	0.00909	CrCrCtD
Methylprednisolone—ABCB1—Vincristine—hematologic cancer	0.00128	0.0119	CbGbCtD
Methylprednisolone—CYP3A4—Nilotinib—hematologic cancer	0.00127	0.0118	CbGbCtD
Methylprednisolone—CYP3A4—Vinorelbine—hematologic cancer	0.00126	0.0117	CbGbCtD
Methylprednisolone—Ciclesonide—Prednisolone—hematologic cancer	0.00125	0.00887	CrCrCtD
Methylprednisolone—Flurandrenolide—Dexamethasone—hematologic cancer	0.00123	0.00877	CrCrCtD
Methylprednisolone—Flurandrenolide—Betamethasone—hematologic cancer	0.00123	0.00877	CrCrCtD
Methylprednisolone—Medrysone—Prednisolone—hematologic cancer	0.0012	0.00853	CrCrCtD
Methylprednisolone—Flumethasone Pivalate—Betamethasone—hematologic cancer	0.00119	0.00847	CrCrCtD
Methylprednisolone—Flumethasone Pivalate—Dexamethasone—hematologic cancer	0.00119	0.00847	CrCrCtD
Methylprednisolone—ABCB1—Cisplatin—hematologic cancer	0.00119	0.0111	CbGbCtD
Methylprednisolone—ABCB1—Etoposide—hematologic cancer	0.00117	0.0109	CbGbCtD
Methylprednisolone—Flumethasone Pivalate—Triamcinolone—hematologic cancer	0.00117	0.00828	CrCrCtD
Methylprednisolone—Fluticasone Propionate—Betamethasone—hematologic cancer	0.00116	0.0082	CrCrCtD
Methylprednisolone—Fluticasone Propionate—Dexamethasone—hematologic cancer	0.00116	0.0082	CrCrCtD
Methylprednisolone—Difluprednate—Betamethasone—hematologic cancer	0.00116	0.0082	CrCrCtD
Methylprednisolone—Halobetasol Propionate—Dexamethasone—hematologic cancer	0.00116	0.0082	CrCrCtD
Methylprednisolone—Halobetasol Propionate—Betamethasone—hematologic cancer	0.00116	0.0082	CrCrCtD
Methylprednisolone—Difluprednate—Dexamethasone—hematologic cancer	0.00116	0.0082	CrCrCtD
Methylprednisolone—CYP3A4—Triamcinolone—hematologic cancer	0.00115	0.0107	CbGbCtD
Methylprednisolone—Fluticasone Propionate—Triamcinolone—hematologic cancer	0.00113	0.00801	CrCrCtD
Methylprednisolone—Difluprednate—Triamcinolone—hematologic cancer	0.00113	0.00801	CrCrCtD
Methylprednisolone—Halobetasol Propionate—Triamcinolone—hematologic cancer	0.00113	0.00801	CrCrCtD
Methylprednisolone—CYP3A4—Dasatinib—hematologic cancer	0.00113	0.0104	CbGbCtD
Methylprednisolone—Flurandrenolide—Prednisolone—hematologic cancer	0.00112	0.00793	CrCrCtD
Methylprednisolone—CYP3A4—Mitoxantrone—hematologic cancer	0.00111	0.0103	CbGbCtD
Methylprednisolone—Testolactone—Betamethasone—hematologic cancer	0.00109	0.00771	CrCrCtD
Methylprednisolone—Testolactone—Dexamethasone—hematologic cancer	0.00109	0.00771	CrCrCtD
Methylprednisolone—Prednicarbate—Dexamethasone—hematologic cancer	0.00109	0.00771	CrCrCtD
Methylprednisolone—Prednicarbate—Betamethasone—hematologic cancer	0.00109	0.00771	CrCrCtD
Methylprednisolone—Clocortolone—Dexamethasone—hematologic cancer	0.00109	0.00771	CrCrCtD
Methylprednisolone—Clocortolone—Betamethasone—hematologic cancer	0.00109	0.00771	CrCrCtD
Methylprednisolone—Fluocinonide—Dexamethasone—hematologic cancer	0.00109	0.00771	CrCrCtD
Methylprednisolone—Fluocinonide—Betamethasone—hematologic cancer	0.00109	0.00771	CrCrCtD
Methylprednisolone—Hydrocortamate—Prednisone—hematologic cancer	0.00107	0.0076	CrCrCtD
Methylprednisolone—Prednicarbate—Triamcinolone—hematologic cancer	0.00106	0.00753	CrCrCtD
Methylprednisolone—Clocortolone—Triamcinolone—hematologic cancer	0.00106	0.00753	CrCrCtD
Methylprednisolone—Fluocinonide—Triamcinolone—hematologic cancer	0.00106	0.00753	CrCrCtD
Methylprednisolone—Testolactone—Triamcinolone—hematologic cancer	0.00106	0.00753	CrCrCtD
Methylprednisolone—Fluocortolone—Betamethasone—hematologic cancer	0.00106	0.00749	CrCrCtD
Methylprednisolone—Fluocortolone—Dexamethasone—hematologic cancer	0.00106	0.00749	CrCrCtD
Methylprednisolone—Hydrocortamate—Prednisolone—hematologic cancer	0.00105	0.00742	CrCrCtD
Methylprednisolone—Cortisone acetate—Prednisone—hematologic cancer	0.00104	0.00737	CrCrCtD
Methylprednisolone—Fluocortolone—Triamcinolone—hematologic cancer	0.00103	0.00732	CrCrCtD
Methylprednisolone—Alclometasone—Dexamethasone—hematologic cancer	0.00103	0.00728	CrCrCtD
Methylprednisolone—Alclometasone—Betamethasone—hematologic cancer	0.00103	0.00728	CrCrCtD
Methylprednisolone—Fluocinolone Acetonide—Betamethasone—hematologic cancer	0.00103	0.00728	CrCrCtD
Methylprednisolone—Fluocinolone Acetonide—Dexamethasone—hematologic cancer	0.00103	0.00728	CrCrCtD
Methylprednisolone—Cortisone acetate—Prednisolone—hematologic cancer	0.00101	0.00719	CrCrCtD
Methylprednisolone—Prednicarbate—Prednisone—hematologic cancer	0.00101	0.00715	CrCrCtD
Methylprednisolone—Testolactone—Prednisone—hematologic cancer	0.00101	0.00715	CrCrCtD
Methylprednisolone—Fluocinolone Acetonide—Triamcinolone—hematologic cancer	0.001	0.00711	CrCrCtD
Methylprednisolone—Alclometasone—Triamcinolone—hematologic cancer	0.001	0.00711	CrCrCtD
Methylprednisolone—Budesonide—Dexamethasone—hematologic cancer	0.000998	0.00709	CrCrCtD
Methylprednisolone—Budesonide—Betamethasone—hematologic cancer	0.000998	0.00709	CrCrCtD
Methylprednisolone—CYP3A4—Betamethasone—hematologic cancer	0.000991	0.0092	CbGbCtD
Methylprednisolone—Prednicarbate—Prednisolone—hematologic cancer	0.000983	0.00698	CrCrCtD
Methylprednisolone—Testolactone—Prednisolone—hematologic cancer	0.000983	0.00698	CrCrCtD
Methylprednisolone—Clocortolone—Prednisolone—hematologic cancer	0.000983	0.00698	CrCrCtD
Methylprednisolone—Fluocortolone—Prednisone—hematologic cancer	0.000978	0.00694	CrCrCtD
Methylprednisolone—CYP3A4—Prednisolone—hematologic cancer	0.000978	0.00907	CbGbCtD
Methylprednisolone—Budesonide—Triamcinolone—hematologic cancer	0.000976	0.00692	CrCrCtD
Methylprednisolone—Fludrocortisone—Betamethasone—hematologic cancer	0.000973	0.0069	CrCrCtD
Methylprednisolone—Prednisone—Betamethasone—hematologic cancer	0.000973	0.0069	CrCrCtD
Methylprednisolone—Diflorasone—Dexamethasone—hematologic cancer	0.000973	0.0069	CrCrCtD
Methylprednisolone—Flunisolide—Dexamethasone—hematologic cancer	0.000973	0.0069	CrCrCtD
Methylprednisolone—Fludrocortisone—Dexamethasone—hematologic cancer	0.000973	0.0069	CrCrCtD
Methylprednisolone—Clobetasol propionate—Dexamethasone—hematologic cancer	0.000973	0.0069	CrCrCtD
Methylprednisolone—Desonide—Betamethasone—hematologic cancer	0.000973	0.0069	CrCrCtD
Methylprednisolone—Desonide—Dexamethasone—hematologic cancer	0.000973	0.0069	CrCrCtD
Methylprednisolone—Clobetasol propionate—Betamethasone—hematologic cancer	0.000973	0.0069	CrCrCtD
Methylprednisolone—Prednisone—Dexamethasone—hematologic cancer	0.000973	0.0069	CrCrCtD
Methylprednisolone—Flunisolide—Betamethasone—hematologic cancer	0.000973	0.0069	CrCrCtD
Methylprednisolone—Diflorasone—Betamethasone—hematologic cancer	0.000973	0.0069	CrCrCtD
Methylprednisolone—ABCB1—Dexamethasone—hematologic cancer	0.000962	0.00893	CbGbCtD
Methylprednisolone—Fluocortolone—Prednisolone—hematologic cancer	0.000955	0.00678	CrCrCtD
Methylprednisolone—Alclometasone—Prednisone—hematologic cancer	0.000951	0.00675	CrCrCtD
Methylprednisolone—Prednisone—Triamcinolone—hematologic cancer	0.00095	0.00675	CrCrCtD
Methylprednisolone—Diflorasone—Triamcinolone—hematologic cancer	0.00095	0.00675	CrCrCtD
Methylprednisolone—Flunisolide—Triamcinolone—hematologic cancer	0.00095	0.00675	CrCrCtD
Methylprednisolone—Fludrocortisone—Triamcinolone—hematologic cancer	0.00095	0.00675	CrCrCtD
Methylprednisolone—Desonide—Triamcinolone—hematologic cancer	0.00095	0.00675	CrCrCtD
Methylprednisolone—Clobetasol propionate—Triamcinolone—hematologic cancer	0.00095	0.00675	CrCrCtD
Methylprednisolone—Paramethasone—Betamethasone—hematologic cancer	0.000948	0.00673	CrCrCtD
Methylprednisolone—Paramethasone—Dexamethasone—hematologic cancer	0.000948	0.00673	CrCrCtD
Methylprednisolone—Alclometasone—Prednisolone—hematologic cancer	0.000929	0.00659	CrCrCtD
Methylprednisolone—Fluocinolone Acetonide—Prednisolone—hematologic cancer	0.000929	0.00659	CrCrCtD
Methylprednisolone—Paramethasone—Triamcinolone—hematologic cancer	0.000926	0.00658	CrCrCtD
Methylprednisolone—Budesonide—Prednisone—hematologic cancer	0.000926	0.00657	CrCrCtD
Methylprednisolone—Desoximetasone—Betamethasone—hematologic cancer	0.000925	0.00657	CrCrCtD
Methylprednisolone—Desoximetasone—Dexamethasone—hematologic cancer	0.000925	0.00657	CrCrCtD
Methylprednisolone—CYP3A4—Prednisone—hematologic cancer	0.000923	0.00857	CbGbCtD
Methylprednisolone—Desoximetasone—Triamcinolone—hematologic cancer	0.000904	0.00642	CrCrCtD
Methylprednisolone—Budesonide—Prednisolone—hematologic cancer	0.000904	0.00641	CrCrCtD
Methylprednisolone—Mometasone—Dexamethasone—hematologic cancer	0.000903	0.00641	CrCrCtD
Methylprednisolone—Triamcinolone—Dexamethasone—hematologic cancer	0.000903	0.00641	CrCrCtD
Methylprednisolone—Triamcinolone—Betamethasone—hematologic cancer	0.000903	0.00641	CrCrCtD
Methylprednisolone—Fluorometholone—Betamethasone—hematologic cancer	0.000903	0.00641	CrCrCtD
Methylprednisolone—Mometasone—Betamethasone—hematologic cancer	0.000903	0.00641	CrCrCtD
Methylprednisolone—Loteprednol—Dexamethasone—hematologic cancer	0.000903	0.00641	CrCrCtD
Methylprednisolone—Fluprednidene Acetate—Betamethasone—hematologic cancer	0.000903	0.00641	CrCrCtD
Methylprednisolone—Fluprednidene Acetate—Dexamethasone—hematologic cancer	0.000903	0.00641	CrCrCtD
Methylprednisolone—Loteprednol—Betamethasone—hematologic cancer	0.000903	0.00641	CrCrCtD
Methylprednisolone—Fluorometholone—Dexamethasone—hematologic cancer	0.000903	0.00641	CrCrCtD
Methylprednisolone—Desonide—Prednisone—hematologic cancer	0.000902	0.0064	CrCrCtD
Methylprednisolone—Diflorasone—Prednisone—hematologic cancer	0.000902	0.0064	CrCrCtD
Methylprednisolone—Fludrocortisone—Prednisone—hematologic cancer	0.000902	0.0064	CrCrCtD
Methylprednisolone—Flunisolide—Prednisone—hematologic cancer	0.000902	0.0064	CrCrCtD
Methylprednisolone—Clobetasol propionate—Prednisone—hematologic cancer	0.000902	0.0064	CrCrCtD
Methylprednisolone—Dexamethasone—Betamethasone—hematologic cancer	0.000883	0.00626	CrCrCtD
Methylprednisolone—Betamethasone—Dexamethasone—hematologic cancer	0.000883	0.00626	CrCrCtD
Methylprednisolone—Rimexolone—Betamethasone—hematologic cancer	0.000883	0.00626	CrCrCtD
Methylprednisolone—Rimexolone—Dexamethasone—hematologic cancer	0.000883	0.00626	CrCrCtD
Methylprednisolone—Fluprednidene Acetate—Triamcinolone—hematologic cancer	0.000883	0.00626	CrCrCtD
Methylprednisolone—Loteprednol—Triamcinolone—hematologic cancer	0.000883	0.00626	CrCrCtD
Methylprednisolone—Mometasone—Triamcinolone—hematologic cancer	0.000883	0.00626	CrCrCtD
Methylprednisolone—Fluorometholone—Triamcinolone—hematologic cancer	0.000883	0.00626	CrCrCtD
Methylprednisolone—Prednisone—Prednisolone—hematologic cancer	0.00088	0.00625	CrCrCtD
Methylprednisolone—Diflorasone—Prednisolone—hematologic cancer	0.00088	0.00625	CrCrCtD
Methylprednisolone—Flunisolide—Prednisolone—hematologic cancer	0.00088	0.00625	CrCrCtD
Methylprednisolone—Fludrocortisone—Prednisolone—hematologic cancer	0.00088	0.00625	CrCrCtD
Methylprednisolone—Desonide—Prednisolone—hematologic cancer	0.00088	0.00625	CrCrCtD
Methylprednisolone—Clobetasol propionate—Prednisolone—hematologic cancer	0.00088	0.00625	CrCrCtD
Methylprednisolone—Paramethasone—Prednisone—hematologic cancer	0.000879	0.00624	CrCrCtD
Methylprednisolone—CYP3A4—Irinotecan—hematologic cancer	0.000875	0.00812	CbGbCtD
Methylprednisolone—Dexamethasone—Triamcinolone—hematologic cancer	0.000862	0.00612	CrCrCtD
Methylprednisolone—Rimexolone—Triamcinolone—hematologic cancer	0.000862	0.00612	CrCrCtD
Methylprednisolone—Betamethasone—Triamcinolone—hematologic cancer	0.000862	0.00612	CrCrCtD
Methylprednisolone—Paramethasone—Prednisolone—hematologic cancer	0.000858	0.00609	CrCrCtD
Methylprednisolone—Desoximetasone—Prednisone—hematologic cancer	0.000858	0.00609	CrCrCtD
Methylprednisolone—Fluorometholone—Prednisone—hematologic cancer	0.000838	0.00595	CrCrCtD
Methylprednisolone—Triamcinolone—Prednisone—hematologic cancer	0.000838	0.00595	CrCrCtD
Methylprednisolone—Mometasone—Prednisone—hematologic cancer	0.000838	0.00595	CrCrCtD
Methylprednisolone—Loteprednol—Prednisone—hematologic cancer	0.000838	0.00595	CrCrCtD
Methylprednisolone—Fluprednidene Acetate—Prednisone—hematologic cancer	0.000838	0.00595	CrCrCtD
Methylprednisolone—Desoximetasone—Prednisolone—hematologic cancer	0.000837	0.00594	CrCrCtD
Methylprednisolone—Prednisolone—Betamethasone—hematologic cancer	0.000826	0.00587	CrCrCtD
Methylprednisolone—Prednisolone—Dexamethasone—hematologic cancer	0.000826	0.00587	CrCrCtD
Methylprednisolone—Betamethasone—Prednisone—hematologic cancer	0.000818	0.00581	CrCrCtD
Methylprednisolone—Dexamethasone—Prednisone—hematologic cancer	0.000818	0.00581	CrCrCtD
Methylprednisolone—Rimexolone—Prednisone—hematologic cancer	0.000818	0.00581	CrCrCtD
Methylprednisolone—Loteprednol—Prednisolone—hematologic cancer	0.000818	0.0058	CrCrCtD
Methylprednisolone—Fluorometholone—Prednisolone—hematologic cancer	0.000818	0.0058	CrCrCtD
Methylprednisolone—Fluprednidene Acetate—Prednisolone—hematologic cancer	0.000818	0.0058	CrCrCtD
Methylprednisolone—Mometasone—Prednisolone—hematologic cancer	0.000818	0.0058	CrCrCtD
Methylprednisolone—Triamcinolone—Prednisolone—hematologic cancer	0.000818	0.0058	CrCrCtD
Methylprednisolone—Prednisolone—Triamcinolone—hematologic cancer	0.000807	0.00573	CrCrCtD
Methylprednisolone—Rimexolone—Prednisolone—hematologic cancer	0.000799	0.00567	CrCrCtD
Methylprednisolone—Dexamethasone—Prednisolone—hematologic cancer	0.000799	0.00567	CrCrCtD
Methylprednisolone—Betamethasone—Prednisolone—hematologic cancer	0.000799	0.00567	CrCrCtD
Methylprednisolone—ABCB1—Doxorubicin—hematologic cancer	0.000798	0.00741	CbGbCtD
Methylprednisolone—Hydrocortisone—Dexamethasone—hematologic cancer	0.000793	0.00563	CrCrCtD
Methylprednisolone—Hydrocortisone—Betamethasone—hematologic cancer	0.000793	0.00563	CrCrCtD
Methylprednisolone—CYP3A4—Vinblastine—hematologic cancer	0.000778	0.00722	CbGbCtD
Methylprednisolone—Hydrocortisone—Triamcinolone—hematologic cancer	0.000775	0.0055	CrCrCtD
Methylprednisolone—ABCB1—Methotrexate—hematologic cancer	0.000773	0.00718	CbGbCtD
Methylprednisolone—Prednisolone—Prednisone—hematologic cancer	0.000766	0.00544	CrCrCtD
Methylprednisolone—CYP3A4—Vincristine—hematologic cancer	0.000765	0.0071	CbGbCtD
Methylprednisolone—Hydrocortisone—Prednisone—hematologic cancer	0.000736	0.00522	CrCrCtD
Methylprednisolone—Hydrocortisone—Prednisolone—hematologic cancer	0.000718	0.0051	CrCrCtD
Methylprednisolone—CYP3A4—Etoposide—hematologic cancer	0.000701	0.00651	CbGbCtD
Methylprednisolone—CYP3A4—Dexamethasone—hematologic cancer	0.000576	0.00535	CbGbCtD
Methylprednisolone—CYP3A4—Doxorubicin—hematologic cancer	0.000478	0.00444	CbGbCtD
Methylprednisolone—Difluprednate—NR3C1—hematologic cancer	3.61e-05	0.0397	CrCbGaD
Methylprednisolone—Prednicarbate—NR3C1—hematologic cancer	3.5e-05	0.0385	CrCbGaD
Methylprednisolone—Clocortolone—NR3C1—hematologic cancer	3.5e-05	0.0385	CrCbGaD
Methylprednisolone—Diflorasone—NR3C1—hematologic cancer	3.32e-05	0.0365	CrCbGaD
Methylprednisolone—Desonide—NR3C1—hematologic cancer	3.32e-05	0.0365	CrCbGaD
Methylprednisolone—Desoximetasone—NR3C1—hematologic cancer	3.23e-05	0.0356	CrCbGaD
Methylprednisolone—Loteprednol—NR3C1—hematologic cancer	3.2e-05	0.0351	CrCbGaD
Methylprednisolone—Fludrocortisone—AR—hematologic cancer	3.15e-05	0.0346	CrCbGaD
Methylprednisolone—Medrysone—NR3C1—hematologic cancer	2.94e-05	0.0323	CrCbGaD
Methylprednisolone—Flurandrenolide—NR3C1—hematologic cancer	2.83e-05	0.0311	CrCbGaD
Methylprednisolone—Flumethasone Pivalate—NR3C1—hematologic cancer	2.78e-05	0.0306	CrCbGaD
Methylprednisolone—Halobetasol Propionate—NR3C1—hematologic cancer	2.74e-05	0.0301	CrCbGaD
Methylprednisolone—Hydrocortamate—NR3C1—hematologic cancer	2.74e-05	0.0301	CrCbGaD
Methylprednisolone—Cortisone acetate—NR3C1—hematologic cancer	2.7e-05	0.0296	CrCbGaD
Methylprednisolone—Budesonide—NR3C1—hematologic cancer	2.55e-05	0.028	CrCbGaD
Methylprednisolone—Mometasone—NR3C1—hematologic cancer	2.42e-05	0.0266	CrCbGaD
Methylprednisolone—Rimexolone—NR3C1—hematologic cancer	2.39e-05	0.0263	CrCbGaD
Methylprednisolone—Fluocinonide—NR3C1—hematologic cancer	2.26e-05	0.0248	CrCbGaD
Methylprednisolone—Medroxyprogesterone Acetate—AR—hematologic cancer	2.23e-05	0.0245	CrCbGaD
Methylprednisolone—Alclometasone—NR3C1—hematologic cancer	2.19e-05	0.0241	CrCbGaD
Methylprednisolone—Fluocinolone Acetonide—NR3C1—hematologic cancer	2.19e-05	0.0241	CrCbGaD
Methylprednisolone—Fludrocortisone—NR3C1—hematologic cancer	2.14e-05	0.0235	CrCbGaD
Methylprednisolone—Clobetasol propionate—NR3C1—hematologic cancer	2.14e-05	0.0235	CrCbGaD
Methylprednisolone—Flunisolide—NR3C1—hematologic cancer	2.14e-05	0.0235	CrCbGaD
Methylprednisolone—Paramethasone—NR3C1—hematologic cancer	2.11e-05	0.0232	CrCbGaD
Methylprednisolone—Ciclesonide—NR3C1—hematologic cancer	2.08e-05	0.0228	CrCbGaD
Methylprednisolone—Fluorometholone—NR3C1—hematologic cancer	2.06e-05	0.0226	CrCbGaD
Methylprednisolone—Medroxyprogesterone Acetate—ESR1—hematologic cancer	1.72e-05	0.0189	CrCbGaD
Methylprednisolone—Triamcinolone—NR3C1—hematologic cancer	1.68e-05	0.0185	CrCbGaD
Methylprednisolone—Prednisone—NR3C1—hematologic cancer	1.52e-05	0.0167	CrCbGaD
Methylprednisolone—Medroxyprogesterone Acetate—NR3C1—hematologic cancer	1.51e-05	0.0166	CrCbGaD
Methylprednisolone—Fluticasone Propionate—NR3C1—hematologic cancer	1.5e-05	0.0165	CrCbGaD
Methylprednisolone—Prednisolone—NR3C1—hematologic cancer	1.4e-05	0.0154	CrCbGaD
Methylprednisolone—Betamethasone—NR3C1—hematologic cancer	1.38e-05	0.0151	CrCbGaD
Methylprednisolone—Hydrocortisone—ABCG2—hematologic cancer	1.24e-05	0.0137	CrCbGaD
Methylprednisolone—Hydrocortisone—NR3C1—hematologic cancer	1.07e-05	0.0118	CrCbGaD
Methylprednisolone—Dexamethasone—ABCG2—hematologic cancer	9.27e-06	0.0102	CrCbGaD
Methylprednisolone—Dexamethasone—NR3C1—hematologic cancer	8e-06	0.00879	CrCbGaD
Methylprednisolone—Prednisone—ALB—hematologic cancer	7.7e-06	0.00846	CrCbGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—PARP1—hematologic cancer	7.48e-06	0.000577	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—UGT1A1—hematologic cancer	7.44e-06	0.000574	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—CDKN1A—hematologic cancer	7.38e-06	0.000569	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	7.38e-06	0.000569	CbGpPWpGaD
Methylprednisolone—Prednisone—ABCB1—hematologic cancer	7.35e-06	0.00808	CrCbGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—TP53—hematologic cancer	7.27e-06	0.00056	CbGpPWpGaD
Methylprednisolone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—hematologic cancer	7.18e-06	0.000553	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—IFNG—hematologic cancer	7.05e-06	0.000543	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—JUN—hematologic cancer	7.03e-06	0.000542	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—STAT1—hematologic cancer	7e-06	0.000539	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	6.94e-06	0.000535	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—IL1B—hematologic cancer	6.79e-06	0.000524	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—CASP3—hematologic cancer	6.77e-06	0.000522	CbGpPWpGaD
Methylprednisolone—Prednisolone—ABCB1—hematologic cancer	6.77e-06	0.00745	CrCbGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—AR—hematologic cancer	6.77e-06	0.000522	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—TET2—hematologic cancer	6.74e-06	0.00052	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—RARA—hematologic cancer	6.74e-06	0.00052	CbGpPWpGaD
Methylprednisolone—CYP3A4—Tryptophan metabolism—MDM2—hematologic cancer	6.66e-06	0.000513	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—IL6—hematologic cancer	6.65e-06	0.000513	CbGpPWpGaD
Methylprednisolone—Betamethasone—ABCB1—hematologic cancer	6.64e-06	0.00729	CrCbGaD
Methylprednisolone—NR3C1—Gene Expression—RPLP1—hematologic cancer	6.61e-06	0.00051	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—STAT3—hematologic cancer	6.59e-06	0.000508	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—JUN—hematologic cancer	6.58e-06	0.000507	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	6.58e-06	0.000507	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—GRB2—hematologic cancer	6.55e-06	0.000505	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—MTR—hematologic cancer	6.54e-06	0.000504	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFA—hematologic cancer	6.53e-06	0.000503	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—EP300—hematologic cancer	6.49e-06	0.0005	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—hematologic cancer	6.29e-06	0.000485	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—STAT5A—hematologic cancer	6.29e-06	0.000485	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—IL1B—hematologic cancer	6.29e-06	0.000485	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—CASP3—hematologic cancer	6.27e-06	0.000484	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—NR0B2—hematologic cancer	6.27e-06	0.000483	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—IL2—hematologic cancer	6.26e-06	0.000483	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—AR—hematologic cancer	6.26e-06	0.000482	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—hematologic cancer	6.24e-06	0.000481	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—GSTT1—hematologic cancer	6.22e-06	0.00048	CbGpPWpGaD
Methylprednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—hematologic cancer	6.2e-06	0.000478	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—hematologic cancer	6.15e-06	0.000474	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—hematologic cancer	6.14e-06	0.000473	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—TGFB1—hematologic cancer	6.1e-06	0.000471	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—EP300—hematologic cancer	6.07e-06	0.000468	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—ATP4A—hematologic cancer	6.02e-06	0.000464	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—SGK1—hematologic cancer	6.02e-06	0.000464	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—ANXA2—hematologic cancer	6.02e-06	0.000464	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—DNMT3A—hematologic cancer	5.98e-06	0.000461	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—ELL—hematologic cancer	5.9e-06	0.000455	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—FGF1—hematologic cancer	5.85e-06	0.000451	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—CDKN2B—hematologic cancer	5.77e-06	0.000445	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—hematologic cancer	5.76e-06	0.000444	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—VEGFA—hematologic cancer	5.75e-06	0.000443	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—TNF—hematologic cancer	5.7e-06	0.00044	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—hematologic cancer	5.66e-06	0.000437	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—NCOR2—hematologic cancer	5.66e-06	0.000436	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—hematologic cancer	5.5e-06	0.000424	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—NCOR1—hematologic cancer	5.47e-06	0.000422	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	5.42e-06	0.000418	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GMPS—hematologic cancer	5.36e-06	0.000414	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PHYH—hematologic cancer	5.36e-06	0.000414	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—FTCD—hematologic cancer	5.36e-06	0.000414	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—VEGFA—hematologic cancer	5.32e-06	0.00041	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—hematologic cancer	5.3e-06	0.000409	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—AGO2—hematologic cancer	5.22e-06	0.000402	CbGpPWpGaD
Methylprednisolone—Hydrocortisone—ABCB1—hematologic cancer	5.18e-06	0.00569	CrCbGaD
Methylprednisolone—NR3C1—Gene Expression—DNMT3B—hematologic cancer	5.11e-06	0.000394	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—H3F3B—hematologic cancer	5.11e-06	0.000394	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—hematologic cancer	4.94e-06	0.000381	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—TNF—hematologic cancer	4.93e-06	0.00038	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—SMPD3—hematologic cancer	4.91e-06	0.000378	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—TGFB1—hematologic cancer	4.89e-06	0.000377	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—ABCC3—hematologic cancer	4.76e-06	0.000367	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK14—hematologic cancer	4.74e-06	0.000365	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—hematologic cancer	4.69e-06	0.000361	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—RPS14—hematologic cancer	4.68e-06	0.00036	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—hematologic cancer	4.67e-06	0.00036	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—hematologic cancer	4.65e-06	0.000358	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—NUP98—hematologic cancer	4.6e-06	0.000355	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—IL6—hematologic cancer	4.6e-06	0.000355	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—TNF—hematologic cancer	4.56e-06	0.000352	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—hematologic cancer	4.53e-06	0.00035	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—hematologic cancer	4.53e-06	0.00035	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—NUP214—hematologic cancer	4.44e-06	0.000342	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	4.35e-06	0.000335	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	4.31e-06	0.000332	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—ESR1—hematologic cancer	4.3e-06	0.000331	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—B3GAT1—hematologic cancer	4.29e-06	0.000331	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—DCK—hematologic cancer	4.29e-06	0.000331	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ASNS—hematologic cancer	4.29e-06	0.000331	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	4.25e-06	0.000328	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—hematologic cancer	4.18e-06	0.000322	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—NOTCH1—hematologic cancer	4.15e-06	0.00032	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—NUP98—hematologic cancer	4.1e-06	0.000316	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—hematologic cancer	4.09e-06	0.000315	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—HSPB1—hematologic cancer	4.09e-06	0.000315	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—EIF4EBP1—hematologic cancer	4.09e-06	0.000315	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—hematologic cancer	4.07e-06	0.000314	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—HDC—hematologic cancer	4.06e-06	0.000313	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	3.98e-06	0.000307	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—IL6—hematologic cancer	3.98e-06	0.000307	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	3.96e-06	0.000306	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—NUP214—hematologic cancer	3.96e-06	0.000305	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—AKT1—hematologic cancer	3.92e-06	0.000302	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—SMC1A—hematologic cancer	3.91e-06	0.000302	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	3.91e-06	0.000301	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—hematologic cancer	3.89e-06	0.0003	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	3.88e-06	0.000299	CbGpPWpGaD
Methylprednisolone—Dexamethasone—ABCB1—hematologic cancer	3.86e-06	0.00424	CrCbGaD
Methylprednisolone—NR3C1—Gene Expression—H3F3A—hematologic cancer	3.84e-06	0.000296	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—CREBBP—hematologic cancer	3.77e-06	0.00029	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CDA—hematologic cancer	3.72e-06	0.000287	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—hematologic cancer	3.7e-06	0.000285	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—EZH2—hematologic cancer	3.68e-06	0.000284	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—PARP1—hematologic cancer	3.6e-06	0.000278	CbGpPWpGaD
Methylprednisolone—Headache—Irinotecan—hematologic cancer	3.59e-06	6.43e-05	CcSEcCtD
Methylprednisolone—Nausea—Ifosfamide—hematologic cancer	3.58e-06	6.42e-05	CcSEcCtD
Methylprednisolone—ABCB1—Metabolism—PC—hematologic cancer	3.58e-06	0.000276	CbGpPWpGaD
Methylprednisolone—Musculoskeletal discomfort—Betamethasone—hematologic cancer	3.57e-06	6.4e-05	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	3.57e-06	6.4e-05	CcSEcCtD
Methylprednisolone—Arthralgia—Prednisone—hematologic cancer	3.56e-06	6.38e-05	CcSEcCtD
Methylprednisolone—Myalgia—Prednisone—hematologic cancer	3.56e-06	6.38e-05	CcSEcCtD
Methylprednisolone—Feeling abnormal—Triamcinolone—hematologic cancer	3.56e-06	6.38e-05	CcSEcCtD
Methylprednisolone—Diarrhoea—Cisplatin—hematologic cancer	3.56e-06	6.38e-05	CcSEcCtD
Methylprednisolone—Anxiety—Prednisone—hematologic cancer	3.55e-06	6.36e-05	CcSEcCtD
Methylprednisolone—Vomiting—Gemcitabine—hematologic cancer	3.55e-06	6.36e-05	CcSEcCtD
Methylprednisolone—Insomnia—Dexamethasone—hematologic cancer	3.55e-06	6.36e-05	CcSEcCtD
Methylprednisolone—Insomnia—Betamethasone—hematologic cancer	3.55e-06	6.36e-05	CcSEcCtD
Methylprednisolone—Bradycardia—Doxorubicin—hematologic cancer	3.54e-06	6.35e-05	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	3.54e-06	6.34e-05	CcSEcCtD
Methylprednisolone—Paraesthesia—Betamethasone—hematologic cancer	3.52e-06	6.31e-05	CcSEcCtD
Methylprednisolone—Paraesthesia—Dexamethasone—hematologic cancer	3.52e-06	6.31e-05	CcSEcCtD
Methylprednisolone—Discomfort—Prednisone—hematologic cancer	3.52e-06	6.31e-05	CcSEcCtD
Methylprednisolone—Mental disorder—Methotrexate—hematologic cancer	3.52e-06	6.31e-05	CcSEcCtD
Methylprednisolone—Rash—Gemcitabine—hematologic cancer	3.52e-06	6.31e-05	CcSEcCtD
Methylprednisolone—Dermatitis—Gemcitabine—hematologic cancer	3.51e-06	6.3e-05	CcSEcCtD
Methylprednisolone—Eye disorder—Epirubicin—hematologic cancer	3.51e-06	6.3e-05	CcSEcCtD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—hematologic cancer	3.51e-06	0.000271	CbGpPWpGaD
Methylprednisolone—Hypersensitivity—Etoposide—hematologic cancer	3.51e-06	6.29e-05	CcSEcCtD
Methylprednisolone—Malnutrition—Methotrexate—hematologic cancer	3.5e-06	6.27e-05	CcSEcCtD
Methylprednisolone—Erythema—Methotrexate—hematologic cancer	3.5e-06	6.27e-05	CcSEcCtD
Methylprednisolone—Haemoglobin—Doxorubicin—hematologic cancer	3.5e-06	6.27e-05	CcSEcCtD
Methylprednisolone—Headache—Gemcitabine—hematologic cancer	3.5e-06	6.27e-05	CcSEcCtD
Methylprednisolone—Nausea—Vincristine—hematologic cancer	3.49e-06	6.26e-05	CcSEcCtD
Methylprednisolone—Cardiac disorder—Epirubicin—hematologic cancer	3.49e-06	6.25e-05	CcSEcCtD
Methylprednisolone—Rhinitis—Doxorubicin—hematologic cancer	3.49e-06	6.25e-05	CcSEcCtD
Methylprednisolone—Haemorrhage—Doxorubicin—hematologic cancer	3.48e-06	6.23e-05	CcSEcCtD
Methylprednisolone—NR3C1—Gene Expression—HDAC2—hematologic cancer	3.47e-06	0.000268	CbGpPWpGaD
Methylprednisolone—Hypersensitivity—Prednisolone—hematologic cancer	3.46e-06	6.21e-05	CcSEcCtD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—hematologic cancer	3.46e-06	0.000267	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—SLC35B2—hematologic cancer	3.46e-06	0.000266	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GBA—hematologic cancer	3.46e-06	0.000266	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—TFRC—hematologic cancer	3.45e-06	0.000266	CbGpPWpGaD
Methylprednisolone—Dyspepsia—Betamethasone—hematologic cancer	3.45e-06	6.19e-05	CcSEcCtD
Methylprednisolone—Dyspepsia—Dexamethasone—hematologic cancer	3.45e-06	6.19e-05	CcSEcCtD
Methylprednisolone—Urticaria—Triamcinolone—hematologic cancer	3.43e-06	6.15e-05	CcSEcCtD
Methylprednisolone—Asthenia—Etoposide—hematologic cancer	3.42e-06	6.13e-05	CcSEcCtD
Methylprednisolone—Connective tissue disorder—Doxorubicin—hematologic cancer	3.42e-06	6.13e-05	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Prednisone—hematologic cancer	3.41e-06	6.12e-05	CcSEcCtD
Methylprednisolone—Angiopathy—Epirubicin—hematologic cancer	3.41e-06	6.11e-05	CcSEcCtD
Methylprednisolone—Nausea—Mitoxantrone—hematologic cancer	3.4e-06	6.1e-05	CcSEcCtD
Methylprednisolone—Nausea—Irinotecan—hematologic cancer	3.4e-06	6.1e-05	CcSEcCtD
Methylprednisolone—Immune system disorder—Epirubicin—hematologic cancer	3.4e-06	6.09e-05	CcSEcCtD
Methylprednisolone—Infection—Prednisone—hematologic cancer	3.39e-06	6.08e-05	CcSEcCtD
Methylprednisolone—Mediastinal disorder—Epirubicin—hematologic cancer	3.39e-06	6.07e-05	CcSEcCtD
Methylprednisolone—Fatigue—Betamethasone—hematologic cancer	3.38e-06	6.06e-05	CcSEcCtD
Methylprednisolone—Fatigue—Dexamethasone—hematologic cancer	3.38e-06	6.06e-05	CcSEcCtD
Methylprednisolone—Pruritus—Etoposide—hematologic cancer	3.37e-06	6.04e-05	CcSEcCtD
Methylprednisolone—Shock—Prednisone—hematologic cancer	3.36e-06	6.02e-05	CcSEcCtD
Methylprednisolone—Arrhythmia—Epirubicin—hematologic cancer	3.36e-06	6.02e-05	CcSEcCtD
Methylprednisolone—Visual impairment—Doxorubicin—hematologic cancer	3.35e-06	6.01e-05	CcSEcCtD
Methylprednisolone—Nervous system disorder—Prednisone—hematologic cancer	3.35e-06	6e-05	CcSEcCtD
Methylprednisolone—Tachycardia—Prednisone—hematologic cancer	3.33e-06	5.97e-05	CcSEcCtD
Methylprednisolone—Skin disorder—Prednisone—hematologic cancer	3.32e-06	5.95e-05	CcSEcCtD
Methylprednisolone—Nausea—Gemcitabine—hematologic cancer	3.31e-06	5.94e-05	CcSEcCtD
Methylprednisolone—Vomiting—Cisplatin—hematologic cancer	3.31e-06	5.93e-05	CcSEcCtD
Methylprednisolone—CYP3A4—Metabolism—PHYH—hematologic cancer	3.3e-06	0.000255	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GMPS—hematologic cancer	3.3e-06	0.000255	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—FTCD—hematologic cancer	3.3e-06	0.000255	CbGpPWpGaD
Methylprednisolone—Hyperhidrosis—Prednisone—hematologic cancer	3.3e-06	5.92e-05	CcSEcCtD
Methylprednisolone—Mental disorder—Epirubicin—hematologic cancer	3.29e-06	5.9e-05	CcSEcCtD
Methylprednisolone—Rash—Cisplatin—hematologic cancer	3.28e-06	5.88e-05	CcSEcCtD
Methylprednisolone—Dermatitis—Cisplatin—hematologic cancer	3.28e-06	5.87e-05	CcSEcCtD
Methylprednisolone—Malnutrition—Epirubicin—hematologic cancer	3.27e-06	5.87e-05	CcSEcCtD
Methylprednisolone—Erythema—Epirubicin—hematologic cancer	3.27e-06	5.87e-05	CcSEcCtD
Methylprednisolone—Diarrhoea—Etoposide—hematologic cancer	3.26e-06	5.84e-05	CcSEcCtD
Methylprednisolone—Eye disorder—Doxorubicin—hematologic cancer	3.25e-06	5.83e-05	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Methotrexate—hematologic cancer	3.24e-06	5.82e-05	CcSEcCtD
Methylprednisolone—Feeling abnormal—Dexamethasone—hematologic cancer	3.23e-06	5.79e-05	CcSEcCtD
Methylprednisolone—Feeling abnormal—Betamethasone—hematologic cancer	3.23e-06	5.79e-05	CcSEcCtD
Methylprednisolone—Cardiac disorder—Doxorubicin—hematologic cancer	3.23e-06	5.79e-05	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Betamethasone—hematologic cancer	3.21e-06	5.75e-05	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Dexamethasone—hematologic cancer	3.21e-06	5.75e-05	CcSEcCtD
Methylprednisolone—Hypersensitivity—Triamcinolone—hematologic cancer	3.18e-06	5.71e-05	CcSEcCtD
Methylprednisolone—ABCB1—Metabolism—MTAP—hematologic cancer	3.16e-06	0.000244	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	3.16e-06	0.000244	CbGpPWpGaD
Methylprednisolone—Angiopathy—Doxorubicin—hematologic cancer	3.16e-06	5.66e-05	CcSEcCtD
Methylprednisolone—Malaise—Methotrexate—hematologic cancer	3.15e-06	5.65e-05	CcSEcCtD
Methylprednisolone—Dizziness—Etoposide—hematologic cancer	3.15e-06	5.65e-05	CcSEcCtD
Methylprednisolone—Immune system disorder—Doxorubicin—hematologic cancer	3.14e-06	5.63e-05	CcSEcCtD
Methylprednisolone—Vertigo—Methotrexate—hematologic cancer	3.14e-06	5.63e-05	CcSEcCtD
Methylprednisolone—Mediastinal disorder—Doxorubicin—hematologic cancer	3.13e-06	5.62e-05	CcSEcCtD
Methylprednisolone—Urticaria—Betamethasone—hematologic cancer	3.11e-06	5.58e-05	CcSEcCtD
Methylprednisolone—Urticaria—Dexamethasone—hematologic cancer	3.11e-06	5.58e-05	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Prednisone—hematologic cancer	3.11e-06	5.58e-05	CcSEcCtD
Methylprednisolone—Dizziness—Prednisolone—hematologic cancer	3.11e-06	5.57e-05	CcSEcCtD
Methylprednisolone—Arrhythmia—Doxorubicin—hematologic cancer	3.11e-06	5.57e-05	CcSEcCtD
Methylprednisolone—Asthenia—Triamcinolone—hematologic cancer	3.1e-06	5.56e-05	CcSEcCtD
Methylprednisolone—Abdominal pain—Dexamethasone—hematologic cancer	3.1e-06	5.56e-05	CcSEcCtD
Methylprednisolone—Abdominal pain—Betamethasone—hematologic cancer	3.1e-06	5.56e-05	CcSEcCtD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	3.1e-06	0.000239	CbGpPWpGaD
Methylprednisolone—Nausea—Cisplatin—hematologic cancer	3.09e-06	5.54e-05	CcSEcCtD
Methylprednisolone—Insomnia—Prednisone—hematologic cancer	3.09e-06	5.54e-05	CcSEcCtD
Methylprednisolone—Paraesthesia—Prednisone—hematologic cancer	3.07e-06	5.5e-05	CcSEcCtD
Methylprednisolone—Pruritus—Triamcinolone—hematologic cancer	3.06e-06	5.48e-05	CcSEcCtD
Methylprednisolone—Mental disorder—Doxorubicin—hematologic cancer	3.05e-06	5.46e-05	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Epirubicin—hematologic cancer	3.04e-06	5.44e-05	CcSEcCtD
Methylprednisolone—Convulsion—Methotrexate—hematologic cancer	3.03e-06	5.43e-05	CcSEcCtD
Methylprednisolone—Vomiting—Etoposide—hematologic cancer	3.03e-06	5.43e-05	CcSEcCtD
Methylprednisolone—Erythema—Doxorubicin—hematologic cancer	3.03e-06	5.43e-05	CcSEcCtD
Methylprednisolone—Malnutrition—Doxorubicin—hematologic cancer	3.03e-06	5.43e-05	CcSEcCtD
Methylprednisolone—CYP3A4—Metabolism—SMPD3—hematologic cancer	3.02e-06	0.000233	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	3.01e-06	0.000232	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—AR—hematologic cancer	3.01e-06	0.000232	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	3.01e-06	0.000232	CbGpPWpGaD
Methylprednisolone—Dyspepsia—Prednisone—hematologic cancer	3.01e-06	5.39e-05	CcSEcCtD
Methylprednisolone—Rash—Etoposide—hematologic cancer	3e-06	5.38e-05	CcSEcCtD
Methylprednisolone—Dermatitis—Etoposide—hematologic cancer	3e-06	5.38e-05	CcSEcCtD
Methylprednisolone—Headache—Etoposide—hematologic cancer	2.98e-06	5.35e-05	CcSEcCtD
Methylprednisolone—Arthralgia—Methotrexate—hematologic cancer	2.98e-06	5.34e-05	CcSEcCtD
Methylprednisolone—Myalgia—Methotrexate—hematologic cancer	2.98e-06	5.34e-05	CcSEcCtD
Methylprednisolone—Rash—Prednisolone—hematologic cancer	2.96e-06	5.31e-05	CcSEcCtD
Methylprednisolone—Dermatitis—Prednisolone—hematologic cancer	2.96e-06	5.31e-05	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	2.96e-06	5.3e-05	CcSEcCtD
Methylprednisolone—Malaise—Epirubicin—hematologic cancer	2.95e-06	5.29e-05	CcSEcCtD
Methylprednisolone—Fatigue—Prednisone—hematologic cancer	2.94e-06	5.28e-05	CcSEcCtD
Methylprednisolone—Headache—Prednisolone—hematologic cancer	2.94e-06	5.28e-05	CcSEcCtD
Methylprednisolone—Discomfort—Methotrexate—hematologic cancer	2.94e-06	5.27e-05	CcSEcCtD
Methylprednisolone—Vertigo—Epirubicin—hematologic cancer	2.94e-06	5.27e-05	CcSEcCtD
Methylprednisolone—Syncope—Epirubicin—hematologic cancer	2.93e-06	5.26e-05	CcSEcCtD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	2.91e-06	0.000225	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	2.91e-06	0.000224	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—CYCS—hematologic cancer	2.9e-06	0.000224	CbGpPWpGaD
Methylprednisolone—Confusional state—Methotrexate—hematologic cancer	2.88e-06	5.16e-05	CcSEcCtD
Methylprednisolone—Loss of consciousness—Epirubicin—hematologic cancer	2.88e-06	5.16e-05	CcSEcCtD
Methylprednisolone—Dizziness—Triamcinolone—hematologic cancer	2.86e-06	5.12e-05	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Methotrexate—hematologic cancer	2.85e-06	5.12e-05	CcSEcCtD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	2.84e-06	0.000219	CbGpPWpGaD
Methylprednisolone—Convulsion—Epirubicin—hematologic cancer	2.83e-06	5.08e-05	CcSEcCtD
Methylprednisolone—Infection—Methotrexate—hematologic cancer	2.83e-06	5.08e-05	CcSEcCtD
Methylprednisolone—Nausea—Etoposide—hematologic cancer	2.83e-06	5.07e-05	CcSEcCtD
Methylprednisolone—Hypertension—Epirubicin—hematologic cancer	2.82e-06	5.06e-05	CcSEcCtD
Methylprednisolone—ABCB1—Metabolism—FHL2—hematologic cancer	2.82e-06	0.000217	CbGpPWpGaD
Methylprednisolone—Feeling abnormal—Prednisone—hematologic cancer	2.81e-06	5.04e-05	CcSEcCtD
Methylprednisolone—Asthenia—Betamethasone—hematologic cancer	2.81e-06	5.04e-05	CcSEcCtD
Methylprednisolone—Asthenia—Dexamethasone—hematologic cancer	2.81e-06	5.04e-05	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Doxorubicin—hematologic cancer	2.81e-06	5.04e-05	CcSEcCtD
Methylprednisolone—Nervous system disorder—Methotrexate—hematologic cancer	2.8e-06	5.02e-05	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Prednisone—hematologic cancer	2.79e-06	5.01e-05	CcSEcCtD
Methylprednisolone—Nausea—Prednisolone—hematologic cancer	2.79e-06	5e-05	CcSEcCtD
Methylprednisolone—Arthralgia—Epirubicin—hematologic cancer	2.79e-06	4.99e-05	CcSEcCtD
Methylprednisolone—Myalgia—Epirubicin—hematologic cancer	2.79e-06	4.99e-05	CcSEcCtD
Methylprednisolone—NR3C1—Gene Expression—CDKN2B—hematologic cancer	2.78e-06	0.000214	CbGpPWpGaD
Methylprednisolone—Anxiety—Epirubicin—hematologic cancer	2.78e-06	4.98e-05	CcSEcCtD
Methylprednisolone—Pruritus—Dexamethasone—hematologic cancer	2.77e-06	4.97e-05	CcSEcCtD
Methylprednisolone—Pruritus—Betamethasone—hematologic cancer	2.77e-06	4.97e-05	CcSEcCtD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	2.77e-06	0.000214	CbGpPWpGaD
Methylprednisolone—Skin disorder—Methotrexate—hematologic cancer	2.77e-06	4.97e-05	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	2.77e-06	4.96e-05	CcSEcCtD
Methylprednisolone—ABCB1—Metabolism—AGRN—hematologic cancer	2.76e-06	0.000213	CbGpPWpGaD
Methylprednisolone—Hyperhidrosis—Methotrexate—hematologic cancer	2.76e-06	4.95e-05	CcSEcCtD
Methylprednisolone—Discomfort—Epirubicin—hematologic cancer	2.75e-06	4.93e-05	CcSEcCtD
Methylprednisolone—Vomiting—Triamcinolone—hematologic cancer	2.75e-06	4.92e-05	CcSEcCtD
Methylprednisolone—Malaise—Doxorubicin—hematologic cancer	2.73e-06	4.89e-05	CcSEcCtD
Methylprednisolone—Rash—Triamcinolone—hematologic cancer	2.72e-06	4.88e-05	CcSEcCtD
Methylprednisolone—Dermatitis—Triamcinolone—hematologic cancer	2.72e-06	4.88e-05	CcSEcCtD
Methylprednisolone—Vertigo—Doxorubicin—hematologic cancer	2.72e-06	4.88e-05	CcSEcCtD
Methylprednisolone—Syncope—Doxorubicin—hematologic cancer	2.72e-06	4.87e-05	CcSEcCtD
Methylprednisolone—Urticaria—Prednisone—hematologic cancer	2.71e-06	4.86e-05	CcSEcCtD
Methylprednisolone—Headache—Triamcinolone—hematologic cancer	2.71e-06	4.85e-05	CcSEcCtD
Methylprednisolone—Abdominal pain—Prednisone—hematologic cancer	2.7e-06	4.84e-05	CcSEcCtD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	2.7e-06	0.000208	CbGpPWpGaD
Methylprednisolone—Confusional state—Epirubicin—hematologic cancer	2.69e-06	4.83e-05	CcSEcCtD
Methylprednisolone—Diarrhoea—Betamethasone—hematologic cancer	2.68e-06	4.81e-05	CcSEcCtD
Methylprednisolone—Diarrhoea—Dexamethasone—hematologic cancer	2.68e-06	4.81e-05	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Epirubicin—hematologic cancer	2.67e-06	4.79e-05	CcSEcCtD
Methylprednisolone—Hypotension—Methotrexate—hematologic cancer	2.67e-06	4.78e-05	CcSEcCtD
Methylprednisolone—Loss of consciousness—Doxorubicin—hematologic cancer	2.66e-06	4.77e-05	CcSEcCtD
Methylprednisolone—Infection—Epirubicin—hematologic cancer	2.65e-06	4.76e-05	CcSEcCtD
Methylprednisolone—CYP3A4—Metabolism—ASNS—hematologic cancer	2.64e-06	0.000204	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—B3GAT1—hematologic cancer	2.64e-06	0.000204	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—DCK—hematologic cancer	2.64e-06	0.000204	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—NCOR1—hematologic cancer	2.63e-06	0.000203	CbGpPWpGaD
Methylprednisolone—Shock—Epirubicin—hematologic cancer	2.63e-06	4.71e-05	CcSEcCtD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	2.63e-06	0.000203	CbGpPWpGaD
Methylprednisolone—Convulsion—Doxorubicin—hematologic cancer	2.62e-06	4.7e-05	CcSEcCtD
Methylprednisolone—ABCB1—Metabolism—HMMR—hematologic cancer	2.62e-06	0.000202	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—IDH2—hematologic cancer	2.62e-06	0.000202	CbGpPWpGaD
Methylprednisolone—Nervous system disorder—Epirubicin—hematologic cancer	2.62e-06	4.69e-05	CcSEcCtD
Methylprednisolone—Hypertension—Doxorubicin—hematologic cancer	2.61e-06	4.69e-05	CcSEcCtD
Methylprednisolone—Tachycardia—Epirubicin—hematologic cancer	2.61e-06	4.67e-05	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.6e-06	4.66e-05	CcSEcCtD
Methylprednisolone—Skin disorder—Epirubicin—hematologic cancer	2.59e-06	4.65e-05	CcSEcCtD
Methylprednisolone—Dizziness—Dexamethasone—hematologic cancer	2.59e-06	4.65e-05	CcSEcCtD
Methylprednisolone—Dizziness—Betamethasone—hematologic cancer	2.59e-06	4.65e-05	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Epirubicin—hematologic cancer	2.58e-06	4.63e-05	CcSEcCtD
Methylprednisolone—Insomnia—Methotrexate—hematologic cancer	2.58e-06	4.63e-05	CcSEcCtD
Methylprednisolone—Myalgia—Doxorubicin—hematologic cancer	2.58e-06	4.62e-05	CcSEcCtD
Methylprednisolone—Arthralgia—Doxorubicin—hematologic cancer	2.58e-06	4.62e-05	CcSEcCtD
Methylprednisolone—Anxiety—Doxorubicin—hematologic cancer	2.57e-06	4.6e-05	CcSEcCtD
Methylprednisolone—Nausea—Triamcinolone—hematologic cancer	2.57e-06	4.6e-05	CcSEcCtD
Methylprednisolone—Paraesthesia—Methotrexate—hematologic cancer	2.56e-06	4.59e-05	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.56e-06	4.59e-05	CcSEcCtD
Methylprednisolone—Discomfort—Doxorubicin—hematologic cancer	2.55e-06	4.57e-05	CcSEcCtD
Methylprednisolone—Hypersensitivity—Prednisone—hematologic cancer	2.52e-06	4.51e-05	CcSEcCtD
Methylprednisolone—Dyspepsia—Methotrexate—hematologic cancer	2.51e-06	4.5e-05	CcSEcCtD
Methylprednisolone—CYP3A4—Metabolism—HDC—hematologic cancer	2.5e-06	0.000193	CbGpPWpGaD
Methylprednisolone—Hypotension—Epirubicin—hematologic cancer	2.5e-06	4.47e-05	CcSEcCtD
Methylprednisolone—Vomiting—Dexamethasone—hematologic cancer	2.49e-06	4.47e-05	CcSEcCtD
Methylprednisolone—Vomiting—Betamethasone—hematologic cancer	2.49e-06	4.47e-05	CcSEcCtD
Methylprednisolone—Confusional state—Doxorubicin—hematologic cancer	2.49e-06	4.47e-05	CcSEcCtD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	2.48e-06	0.000192	CbGpPWpGaD
Methylprednisolone—Rash—Dexamethasone—hematologic cancer	2.47e-06	4.43e-05	CcSEcCtD
Methylprednisolone—Rash—Betamethasone—hematologic cancer	2.47e-06	4.43e-05	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Doxorubicin—hematologic cancer	2.47e-06	4.43e-05	CcSEcCtD
Methylprednisolone—Dermatitis—Betamethasone—hematologic cancer	2.47e-06	4.43e-05	CcSEcCtD
Methylprednisolone—Dermatitis—Dexamethasone—hematologic cancer	2.47e-06	4.43e-05	CcSEcCtD
Methylprednisolone—ABCB1—Metabolism—ARNTL—hematologic cancer	2.46e-06	0.00019	CbGpPWpGaD
Methylprednisolone—Fatigue—Methotrexate—hematologic cancer	2.46e-06	4.41e-05	CcSEcCtD
Methylprednisolone—Headache—Betamethasone—hematologic cancer	2.46e-06	4.4e-05	CcSEcCtD
Methylprednisolone—Headache—Dexamethasone—hematologic cancer	2.46e-06	4.4e-05	CcSEcCtD
Methylprednisolone—Infection—Doxorubicin—hematologic cancer	2.45e-06	4.4e-05	CcSEcCtD
Methylprednisolone—Asthenia—Prednisone—hematologic cancer	2.45e-06	4.39e-05	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.43e-06	4.36e-05	CcSEcCtD
Methylprednisolone—Shock—Doxorubicin—hematologic cancer	2.43e-06	4.36e-05	CcSEcCtD
Methylprednisolone—Nervous system disorder—Doxorubicin—hematologic cancer	2.42e-06	4.34e-05	CcSEcCtD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	2.42e-06	0.000186	CbGpPWpGaD
Methylprednisolone—Pruritus—Prednisone—hematologic cancer	2.42e-06	4.33e-05	CcSEcCtD
Methylprednisolone—Insomnia—Epirubicin—hematologic cancer	2.42e-06	4.33e-05	CcSEcCtD
Methylprednisolone—Tachycardia—Doxorubicin—hematologic cancer	2.41e-06	4.32e-05	CcSEcCtD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	2.41e-06	0.000186	CbGpPWpGaD
Methylprednisolone—Skin disorder—Doxorubicin—hematologic cancer	2.4e-06	4.3e-05	CcSEcCtD
Methylprednisolone—Paraesthesia—Epirubicin—hematologic cancer	2.4e-06	4.3e-05	CcSEcCtD
Methylprednisolone—ABCB1—Metabolism—CA9—hematologic cancer	2.4e-06	0.000185	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ACP5—hematologic cancer	2.4e-06	0.000185	CbGpPWpGaD
Methylprednisolone—Hyperhidrosis—Doxorubicin—hematologic cancer	2.39e-06	4.28e-05	CcSEcCtD
Methylprednisolone—ABCB1—Metabolism—NCOR2—hematologic cancer	2.36e-06	0.000182	CbGpPWpGaD
Methylprednisolone—Feeling abnormal—Methotrexate—hematologic cancer	2.35e-06	4.22e-05	CcSEcCtD
Methylprednisolone—Dyspepsia—Epirubicin—hematologic cancer	2.35e-06	4.21e-05	CcSEcCtD
Methylprednisolone—Diarrhoea—Prednisone—hematologic cancer	2.34e-06	4.19e-05	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Methotrexate—hematologic cancer	2.33e-06	4.18e-05	CcSEcCtD
Methylprednisolone—Nausea—Betamethasone—hematologic cancer	2.33e-06	4.17e-05	CcSEcCtD
Methylprednisolone—Nausea—Dexamethasone—hematologic cancer	2.33e-06	4.17e-05	CcSEcCtD
Methylprednisolone—Hypotension—Doxorubicin—hematologic cancer	2.31e-06	4.14e-05	CcSEcCtD
Methylprednisolone—Fatigue—Epirubicin—hematologic cancer	2.3e-06	4.13e-05	CcSEcCtD
Methylprednisolone—CYP3A4—Metabolism—CDA—hematologic cancer	2.29e-06	0.000177	CbGpPWpGaD
Methylprednisolone—Urticaria—Methotrexate—hematologic cancer	2.27e-06	4.06e-05	CcSEcCtD
Methylprednisolone—Dizziness—Prednisone—hematologic cancer	2.26e-06	4.05e-05	CcSEcCtD
Methylprednisolone—Abdominal pain—Methotrexate—hematologic cancer	2.26e-06	4.04e-05	CcSEcCtD
Methylprednisolone—ABCB1—Metabolism—IDH1—hematologic cancer	2.25e-06	0.000174	CbGpPWpGaD
Methylprednisolone—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.25e-06	4.04e-05	CcSEcCtD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	2.25e-06	0.000174	CbGpPWpGaD
Methylprednisolone—Insomnia—Doxorubicin—hematologic cancer	2.23e-06	4.01e-05	CcSEcCtD
Methylprednisolone—NR3C1—Generic Transcription Pathway—MYC—hematologic cancer	2.23e-06	0.000172	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	2.23e-06	0.000172	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GSTO1—hematologic cancer	2.23e-06	0.000172	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ABCC3—hematologic cancer	2.23e-06	0.000172	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—TXN—hematologic cancer	2.23e-06	0.000172	CbGpPWpGaD
Methylprednisolone—Paraesthesia—Doxorubicin—hematologic cancer	2.22e-06	3.98e-05	CcSEcCtD
Methylprednisolone—CYP3A4—Metabolism—PC—hematologic cancer	2.2e-06	0.00017	CbGpPWpGaD
Methylprednisolone—Feeling abnormal—Epirubicin—hematologic cancer	2.2e-06	3.94e-05	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Epirubicin—hematologic cancer	2.18e-06	3.91e-05	CcSEcCtD
Methylprednisolone—ABCB1—Metabolism—SPHK1—hematologic cancer	2.18e-06	0.000168	CbGpPWpGaD
Methylprednisolone—Dyspepsia—Doxorubicin—hematologic cancer	2.18e-06	3.9e-05	CcSEcCtD
Methylprednisolone—Vomiting—Prednisone—hematologic cancer	2.17e-06	3.89e-05	CcSEcCtD
Methylprednisolone—Rash—Prednisone—hematologic cancer	2.15e-06	3.86e-05	CcSEcCtD
Methylprednisolone—Dermatitis—Prednisone—hematologic cancer	2.15e-06	3.86e-05	CcSEcCtD
Methylprednisolone—Headache—Prednisone—hematologic cancer	2.14e-06	3.83e-05	CcSEcCtD
Methylprednisolone—Fatigue—Doxorubicin—hematologic cancer	2.13e-06	3.82e-05	CcSEcCtD
Methylprednisolone—CYP3A4—Metabolism—SLC35B2—hematologic cancer	2.13e-06	0.000164	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GBA—hematologic cancer	2.13e-06	0.000164	CbGpPWpGaD
Methylprednisolone—Urticaria—Epirubicin—hematologic cancer	2.12e-06	3.8e-05	CcSEcCtD
Methylprednisolone—Abdominal pain—Epirubicin—hematologic cancer	2.11e-06	3.78e-05	CcSEcCtD
Methylprednisolone—NR3C1—Gene Expression—MAPK14—hematologic cancer	2.11e-06	0.000163	CbGpPWpGaD
Methylprednisolone—Hypersensitivity—Methotrexate—hematologic cancer	2.1e-06	3.77e-05	CcSEcCtD
Methylprednisolone—ABCB1—Metabolism—UGT1A1—hematologic cancer	2.09e-06	0.000161	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—ESR1—hematologic cancer	2.07e-06	0.000159	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	2.05e-06	0.000158	CbGpPWpGaD
Methylprednisolone—Asthenia—Methotrexate—hematologic cancer	2.05e-06	3.67e-05	CcSEcCtD
Methylprednisolone—ABCB1—Metabolism—CRABP1—hematologic cancer	2.04e-06	0.000157	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—SLC22A1—hematologic cancer	2.04e-06	0.000157	CbGpPWpGaD
Methylprednisolone—Feeling abnormal—Doxorubicin—hematologic cancer	2.04e-06	3.65e-05	CcSEcCtD
Methylprednisolone—Nausea—Prednisone—hematologic cancer	2.03e-06	3.64e-05	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Doxorubicin—hematologic cancer	2.02e-06	3.62e-05	CcSEcCtD
Methylprednisolone—Pruritus—Methotrexate—hematologic cancer	2.02e-06	3.62e-05	CcSEcCtD
Methylprednisolone—NR3C1—Gene Expression—NOTCH1—hematologic cancer	2e-06	0.000154	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ALOX5—hematologic cancer	1.99e-06	0.000153	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	1.98e-06	0.000153	CbGpPWpGaD
Methylprednisolone—Hypersensitivity—Epirubicin—hematologic cancer	1.97e-06	3.53e-05	CcSEcCtD
Methylprednisolone—Urticaria—Doxorubicin—hematologic cancer	1.96e-06	3.52e-05	CcSEcCtD
Methylprednisolone—Abdominal pain—Doxorubicin—hematologic cancer	1.95e-06	3.5e-05	CcSEcCtD
Methylprednisolone—Diarrhoea—Methotrexate—hematologic cancer	1.95e-06	3.5e-05	CcSEcCtD
Methylprednisolone—CYP3A4—Metabolism—MTAP—hematologic cancer	1.95e-06	0.00015	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—NUP98—hematologic cancer	1.92e-06	0.000148	CbGpPWpGaD
Methylprednisolone—Asthenia—Epirubicin—hematologic cancer	1.92e-06	3.43e-05	CcSEcCtD
Methylprednisolone—Pruritus—Epirubicin—hematologic cancer	1.89e-06	3.39e-05	CcSEcCtD
Methylprednisolone—Dizziness—Methotrexate—hematologic cancer	1.89e-06	3.38e-05	CcSEcCtD
Methylprednisolone—ABCB1—Metabolism—ADCY7—hematologic cancer	1.87e-06	0.000144	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—NCOA3—hematologic cancer	1.87e-06	0.000144	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—NUP214—hematologic cancer	1.85e-06	0.000143	CbGpPWpGaD
Methylprednisolone—Diarrhoea—Epirubicin—hematologic cancer	1.83e-06	3.28e-05	CcSEcCtD
Methylprednisolone—Hypersensitivity—Doxorubicin—hematologic cancer	1.82e-06	3.26e-05	CcSEcCtD
Methylprednisolone—ABCB1—Metabolism—ABCG2—hematologic cancer	1.82e-06	0.00014	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—MTR—hematologic cancer	1.82e-06	0.00014	CbGpPWpGaD
Methylprednisolone—Vomiting—Methotrexate—hematologic cancer	1.81e-06	3.25e-05	CcSEcCtD
Methylprednisolone—NR3C1—Gene Expression—CREBBP—hematologic cancer	1.81e-06	0.00014	CbGpPWpGaD
Methylprednisolone—Rash—Methotrexate—hematologic cancer	1.8e-06	3.23e-05	CcSEcCtD
Methylprednisolone—Dermatitis—Methotrexate—hematologic cancer	1.8e-06	3.22e-05	CcSEcCtD
Methylprednisolone—Headache—Methotrexate—hematologic cancer	1.79e-06	3.2e-05	CcSEcCtD
Methylprednisolone—ABCB1—Metabolism—ENO2—hematologic cancer	1.78e-06	0.000137	CbGpPWpGaD
Methylprednisolone—Asthenia—Doxorubicin—hematologic cancer	1.77e-06	3.18e-05	CcSEcCtD
Methylprednisolone—Dizziness—Epirubicin—hematologic cancer	1.77e-06	3.17e-05	CcSEcCtD
Methylprednisolone—Pruritus—Doxorubicin—hematologic cancer	1.75e-06	3.13e-05	CcSEcCtD
Methylprednisolone—CYP3A4—Metabolism—FHL2—hematologic cancer	1.74e-06	0.000134	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GSTT1—hematologic cancer	1.73e-06	0.000133	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—AGRN—hematologic cancer	1.7e-06	0.000131	CbGpPWpGaD
Methylprednisolone—Vomiting—Epirubicin—hematologic cancer	1.7e-06	3.04e-05	CcSEcCtD
Methylprednisolone—Nausea—Methotrexate—hematologic cancer	1.69e-06	3.04e-05	CcSEcCtD
Methylprednisolone—Diarrhoea—Doxorubicin—hematologic cancer	1.69e-06	3.03e-05	CcSEcCtD
Methylprednisolone—ABCB1—Metabolism—SDC1—hematologic cancer	1.69e-06	0.00013	CbGpPWpGaD
Methylprednisolone—Rash—Epirubicin—hematologic cancer	1.68e-06	3.02e-05	CcSEcCtD
Methylprednisolone—Dermatitis—Epirubicin—hematologic cancer	1.68e-06	3.02e-05	CcSEcCtD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	1.68e-06	0.000129	CbGpPWpGaD
Methylprednisolone—Headache—Epirubicin—hematologic cancer	1.67e-06	3e-05	CcSEcCtD
Methylprednisolone—Dizziness—Doxorubicin—hematologic cancer	1.63e-06	2.93e-05	CcSEcCtD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.62e-06	0.000125	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—HMMR—hematologic cancer	1.61e-06	0.000124	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—IDH2—hematologic cancer	1.61e-06	0.000124	CbGpPWpGaD
Methylprednisolone—Nausea—Epirubicin—hematologic cancer	1.59e-06	2.84e-05	CcSEcCtD
Methylprednisolone—Vomiting—Doxorubicin—hematologic cancer	1.57e-06	2.82e-05	CcSEcCtD
Methylprednisolone—Rash—Doxorubicin—hematologic cancer	1.56e-06	2.79e-05	CcSEcCtD
Methylprednisolone—Dermatitis—Doxorubicin—hematologic cancer	1.56e-06	2.79e-05	CcSEcCtD
Methylprednisolone—Headache—Doxorubicin—hematologic cancer	1.55e-06	2.77e-05	CcSEcCtD
Methylprednisolone—CYP3A4—Metabolism—ARNTL—hematologic cancer	1.52e-06	0.000117	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	1.51e-06	0.000117	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CA9—hematologic cancer	1.48e-06	0.000114	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ACP5—hematologic cancer	1.48e-06	0.000114	CbGpPWpGaD
Methylprednisolone—Nausea—Doxorubicin—hematologic cancer	1.47e-06	2.63e-05	CcSEcCtD
Methylprednisolone—CYP3A4—Metabolism—NCOR2—hematologic cancer	1.46e-06	0.000112	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CD44—hematologic cancer	1.44e-06	0.000111	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—NQO1—hematologic cancer	1.44e-06	0.000111	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—IDH1—hematologic cancer	1.39e-06	0.000107	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GSTO1—hematologic cancer	1.37e-06	0.000106	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—TXN—hematologic cancer	1.37e-06	0.000106	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ABCC3—hematologic cancer	1.37e-06	0.000106	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CYCS—hematologic cancer	1.36e-06	0.000105	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—HSP90AA1—hematologic cancer	1.35e-06	0.000104	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—SPHK1—hematologic cancer	1.34e-06	0.000104	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—UGT1A1—hematologic cancer	1.29e-06	9.95e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CRABP1—hematologic cancer	1.25e-06	9.68e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—SLC22A1—hematologic cancer	1.25e-06	9.68e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ALOX5—hematologic cancer	1.22e-06	9.43e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GSTP1—hematologic cancer	1.2e-06	9.23e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—NUP98—hematologic cancer	1.18e-06	9.13e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ADCY7—hematologic cancer	1.15e-06	8.87e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—NCOA3—hematologic cancer	1.15e-06	8.87e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—NUP214—hematologic cancer	1.14e-06	8.8e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ABCG2—hematologic cancer	1.12e-06	8.62e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—MTR—hematologic cancer	1.12e-06	8.62e-05	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—MAPK3—hematologic cancer	1.11e-06	8.53e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GSTM1—hematologic cancer	1.1e-06	8.48e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—NCOR1—hematologic cancer	1.1e-06	8.48e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ENO2—hematologic cancer	1.1e-06	8.46e-05	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—MYC—hematologic cancer	1.08e-06	8.3e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GSTT1—hematologic cancer	1.06e-06	8.2e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—SDC1—hematologic cancer	1.04e-06	8.02e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—MTHFR—hematologic cancer	9.72e-07	7.5e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CD44—hematologic cancer	8.84e-07	6.82e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—NQO1—hematologic cancer	8.84e-07	6.82e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CYCS—hematologic cancer	8.37e-07	6.45e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	8.31e-07	6.41e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PIK3CG—hematologic cancer	8.17e-07	6.3e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CREBBP—hematologic cancer	7.57e-07	5.84e-05	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—AKT1—hematologic cancer	7.46e-07	5.75e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GSTP1—hematologic cancer	7.37e-07	5.69e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PIK3CD—hematologic cancer	7.18e-07	5.54e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ALB—hematologic cancer	7.09e-07	5.47e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ABCB1—hematologic cancer	6.98e-07	5.38e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PIK3R1—hematologic cancer	6.78e-07	5.23e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GSTM1—hematologic cancer	6.78e-07	5.23e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—NCOR1—hematologic cancer	6.78e-07	5.23e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PIK3CB—hematologic cancer	6.26e-07	4.83e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—MTHFR—hematologic cancer	5.99e-07	4.62e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PTEN—hematologic cancer	5.41e-07	4.17e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—EP300—hematologic cancer	5.16e-07	3.98e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PIK3CG—hematologic cancer	5.03e-07	3.88e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CREBBP—hematologic cancer	4.67e-07	3.6e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PIK3CD—hematologic cancer	4.42e-07	3.41e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ALB—hematologic cancer	4.37e-07	3.37e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PIK3R1—hematologic cancer	4.18e-07	3.22e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PIK3CB—hematologic cancer	3.86e-07	2.97e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PIK3CA—hematologic cancer	3.82e-07	2.94e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PTEN—hematologic cancer	3.33e-07	2.57e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—EP300—hematologic cancer	3.18e-07	2.45e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—AKT1—hematologic cancer	3.12e-07	2.4e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PIK3CA—hematologic cancer	2.35e-07	1.81e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—AKT1—hematologic cancer	1.92e-07	1.48e-05	CbGpPWpGaD
